Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 29 of 29
Comparison of Two Methods to Diagnose Coronary Artery Disease
NCT00063531
Hypertonic Saline Use in Preeclampsia
NCT00181077
Induced Hypertension for Acute Ischemic Stroke
NCT00227448
Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration
NCT01570790
Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices
NCT01130896
The Effect of Statin Use on Vascular Function in Hypertensive Subjects
NCT00181181
The Therapeutic Workplace Initiation Study
NCT00249470
Medtronic MiniMed Implantable Insulin Pump
NCT00298740
Child and Adolescent Anxiety Disorders (CAMS)
NCT00052078
Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)
NCT00066937
Fatigue and Cancer Treatment(FACT)- an Exercise Intervention
NCT00181129
The Effect of Weight Loss and Exercise on Knee Osteoarthritis
NCT00061490
Fetal Neurobehavioral Development in Methadone Maintained Pregnancies
NCT00067184
Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence
NCT00233233
Evaluation of Adolescent Smoking Cessation Programs
NCT00714207
Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
NCT00305630
Family Spirit Study
NCT00356551
Lupus Atherosclerosis Prevention Study
NCT00120887
Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement
NCT00386464
Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania
NCT00347607
A Therapeutic Workplace for Alcohol Dependence
NCT00183144
Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage
NCT00029315
Imaging Techniques in Body Magnetic Resonance Imaging "MRI"
NCT00362557
Genetic Modifiers of Cystic Fibrosis: Sibling Study
NCT00037778
Community-Based Violence Prevention for High-Risk Youth
NCT00444197
Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia
NCT00347776
Psychological Treatments for Scleroderma
NCT00007267
DNA Vaccine for Ragweed Allergic Adults
NCT00346086
Assessment and Treatment of Caffeine Dependence
NCT00338195
Recovery Housing and Drug Abuse Treatment Outcome
NCT03278496
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
NCT00033020
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
NCT00033007
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
NCT00181168
HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
NCT01423643
Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
NCT00125060
Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania
NCT00347763
Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition
NCT00740701
Early Home Visitation Program to Promote Good Health and Development in Children at Risk for Abuse
NCT00218751
The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation
NCT00181142
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
NCT00692991
Evaluation of the Healthy Families Alaska Program
NCT00216710
A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents
NCT00348621
Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
NCT00010413
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
NCT00010387
Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
NCT00010400
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2
NCT00249457
Opioid Maintenance Medications Comparison Study
NCT00344812
Naltrexone Treatment for Alcoholism
NCT00000438
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.